Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses

Abstract Background Porcine Circovirus Type 2 (PCV2) is a pathogen that has the ability to cause often devastating disease manifestations in pig populations with major economic implications. How PCV2 establishes subclinical persistence and why certain individuals progress to lethal lymphoid depletio...

Full description

Bibliographic Details
Main Authors: Nicolaas Van Renne, Ruifang Wei, Nathalie Pochet, Hans J. Nauwynck
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12864-018-5217-5
id doaj-1e5e9989d0c64cf087e63837571a748f
record_format Article
spelling doaj-1e5e9989d0c64cf087e63837571a748f2020-11-25T00:29:23ZengBMCBMC Genomics1471-21642018-11-0119111510.1186/s12864-018-5217-5Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responsesNicolaas Van Renne0Ruifang Wei1Nathalie Pochet2Hans J. Nauwynck3Laboratory of Virology, Faculty of Veterinary Medicine, Ghent UniversityLaboratory of Virology, Faculty of Veterinary Medicine, Ghent UniversityAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical SchoolLaboratory of Virology, Faculty of Veterinary Medicine, Ghent UniversityAbstract Background Porcine Circovirus Type 2 (PCV2) is a pathogen that has the ability to cause often devastating disease manifestations in pig populations with major economic implications. How PCV2 establishes subclinical persistence and why certain individuals progress to lethal lymphoid depletion remain to be elucidated. Results Here we present PorSignDB, a gene signature database describing in vivo porcine tissue physiology that we generated from a large compendium of in vivo transcriptional profiles and that we subsequently leveraged for deciphering the distinct physiological states underlying PCV2-affected lymph nodes. This systems genomics approach indicated that subclinical PCV2 infections suppress a myeloid leukocyte mediated immune response. However, in contrast an inflammatory myeloid cell activation is promoted in PCV2 patients with clinical manifestations. Functional genomics further uncovered STAT3 as a druggable PCV2 host factor candidate. Moreover, IL-2 supplementation of primary lymphocytes enabled ex vivo study of PCV2 replication in its target cell, the lymphoblast. Conclusion Our systematic dissection of the mechanistic basis of PCV2 reveals that subclinical and clinical PCV2 display two diametrically opposed immunotranscriptomic recalibrations that represent distinct physiological states in vivo, which suggests a paradigm shift in this field. Finally, our PorSignDB signature database is publicly available as a community resource (http://www.vetvirology.ugent.be/PorSignDB/, included in Gene Sets from Community Contributors http://software.broadinstitute.org/gsea/msigdb/contributed_genesets.jsp) and provides systems biologists with a valuable tool for catalyzing studies of human and veterinary disease. Finally, a primary porcine lymphoblast cell culture system paves the way for unraveling the impact of host genetics on PCV2 replication.http://link.springer.com/article/10.1186/s12864-018-5217-5PCV2PorSignDBPMWSSTAT3IL-2Pathogenesis
collection DOAJ
language English
format Article
sources DOAJ
author Nicolaas Van Renne
Ruifang Wei
Nathalie Pochet
Hans J. Nauwynck
spellingShingle Nicolaas Van Renne
Ruifang Wei
Nathalie Pochet
Hans J. Nauwynck
Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
BMC Genomics
PCV2
PorSignDB
PMWS
STAT3
IL-2
Pathogenesis
author_facet Nicolaas Van Renne
Ruifang Wei
Nathalie Pochet
Hans J. Nauwynck
author_sort Nicolaas Van Renne
title Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
title_short Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
title_full Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
title_fullStr Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
title_full_unstemmed Dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
title_sort dissecting clinical outcome of porcine circovirus type 2 with in vivo derived transcriptomic signatures of host tissue responses
publisher BMC
series BMC Genomics
issn 1471-2164
publishDate 2018-11-01
description Abstract Background Porcine Circovirus Type 2 (PCV2) is a pathogen that has the ability to cause often devastating disease manifestations in pig populations with major economic implications. How PCV2 establishes subclinical persistence and why certain individuals progress to lethal lymphoid depletion remain to be elucidated. Results Here we present PorSignDB, a gene signature database describing in vivo porcine tissue physiology that we generated from a large compendium of in vivo transcriptional profiles and that we subsequently leveraged for deciphering the distinct physiological states underlying PCV2-affected lymph nodes. This systems genomics approach indicated that subclinical PCV2 infections suppress a myeloid leukocyte mediated immune response. However, in contrast an inflammatory myeloid cell activation is promoted in PCV2 patients with clinical manifestations. Functional genomics further uncovered STAT3 as a druggable PCV2 host factor candidate. Moreover, IL-2 supplementation of primary lymphocytes enabled ex vivo study of PCV2 replication in its target cell, the lymphoblast. Conclusion Our systematic dissection of the mechanistic basis of PCV2 reveals that subclinical and clinical PCV2 display two diametrically opposed immunotranscriptomic recalibrations that represent distinct physiological states in vivo, which suggests a paradigm shift in this field. Finally, our PorSignDB signature database is publicly available as a community resource (http://www.vetvirology.ugent.be/PorSignDB/, included in Gene Sets from Community Contributors http://software.broadinstitute.org/gsea/msigdb/contributed_genesets.jsp) and provides systems biologists with a valuable tool for catalyzing studies of human and veterinary disease. Finally, a primary porcine lymphoblast cell culture system paves the way for unraveling the impact of host genetics on PCV2 replication.
topic PCV2
PorSignDB
PMWS
STAT3
IL-2
Pathogenesis
url http://link.springer.com/article/10.1186/s12864-018-5217-5
work_keys_str_mv AT nicolaasvanrenne dissectingclinicaloutcomeofporcinecircovirustype2withinvivoderivedtranscriptomicsignaturesofhosttissueresponses
AT ruifangwei dissectingclinicaloutcomeofporcinecircovirustype2withinvivoderivedtranscriptomicsignaturesofhosttissueresponses
AT nathaliepochet dissectingclinicaloutcomeofporcinecircovirustype2withinvivoderivedtranscriptomicsignaturesofhosttissueresponses
AT hansjnauwynck dissectingclinicaloutcomeofporcinecircovirustype2withinvivoderivedtranscriptomicsignaturesofhosttissueresponses
_version_ 1725331680625950720